about
Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cellsIn vitro and In vivo Model Systems for Hemophilia A Gene Therapy.Cornerstones of CRISPR-Cas in drug discovery and therapy.CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Engineering Factor Viii for Hemophilia Gene Therapy.
@ast
Engineering Factor Viii for Hemophilia Gene Therapy.
@en
type
label
Engineering Factor Viii for Hemophilia Gene Therapy.
@ast
Engineering Factor Viii for Hemophilia Gene Therapy.
@en
prefLabel
Engineering Factor Viii for Hemophilia Gene Therapy.
@ast
Engineering Factor Viii for Hemophilia Gene Therapy.
@en
P2093
P2860
P921
P356
P1476
Engineering Factor Viii for Hemophilia Gene Therapy.
@en
P2093
Andrea R Moore
Jenni A Firrman
Nianli Sang
Sean A Roberts
Weidong Xiao
P2860
P356
10.4172/2157-7412.S1-006
P577
2011-12-01T00:00:00Z